Skip to main content

WPI 5 (Solifenacin Succinate 5 mg)

Pill with imprint WPI 5 is Yellow, Round and has been identified as Solifenacin Succinate 5 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Solifenacin is used in the treatment of overactive bladder; urinary incontinence; urinary frequency; neurogenic bladder; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Solifenacin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 5

Solifenacin succinate 5 mg WPI 5

Solifenacin Succinate

Imprint
WPI 5
Strength
5 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Watson Pharma Private Limited
National Drug Code (NDC)
00591-3795

Get help with Imprint Code FAQs.

Related Images for "WPI 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.